(228 days)
No
The summary describes a mechanical feeding tube and its components, with no mention of software, algorithms, or data processing that would indicate AI/ML. The performance studies focus on physical and material properties.
Yes.
The device administers nutrition, fluids, and medications, which are therapeutic actions for patients unable to manage nutritional intake normally.
No
Explanation: The device is a feeding tube used for administering nutrition, fluids, and medications. It does not perform any diagnostic functions.
No
The device description clearly outlines physical components like a silicone tube, balloon retention device, external skin disc, and an ENFit Y-Port adapter, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for the administration of nutrition, fluids, and medications directly to the stomach. This is a therapeutic and supportive function, not a diagnostic one.
- Device Description: The description details a physical tube with a balloon and external disc for retention, designed for direct delivery into the body. This is consistent with a medical device used for treatment or support, not for analyzing samples outside the body.
- Lack of Diagnostic Elements: There is no mention of the device being used to test or analyze biological samples (like blood, urine, tissue, etc.) to provide information about a patient's health status, disease, or condition.
- Performance Studies: The performance studies focus on the physical and functional characteristics of the tube itself (leak testing, tensile strength, flow rate, biocompatibility, etc.), which are relevant to a device used for delivery into the body, not for diagnostic testing.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide diagnostic information. This device's function is entirely focused on delivering substances into the body.
N/A
Intended Use / Indications for Use
The Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port is indicated for use in an established gastrostomy tract as a replacement tube for the administration of nutrition, fluids, and medications to the stomach of a patient, 2 years and older, that are physically unable to manage nutritional intake through normal mastication and deglutition.
Product codes
KNT, PIF
Device Description
The Kangaroo™ Gastrostomy Feeding Tube is a silicone qastrostomy tube with a balloon retention device located at the tip of the tube. An external skin disc is provided on the outer lumen of the device and is used in conjunction with the balloon to provide a secure retention system for the Kanqaroo™ Gastrostomy Feeding Tube. The ENFit Y-Port Enteral Adapter is secured within the funnel end of the Gastrostomy Tube Lumen. The Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port is packaged with a packet of water-soluble jelly used to ease the insertion of the device.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
stomach
Indicated Patient Age Range
2 years and older
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Laboratory testing was completed to support substantial equivalence between the proposed device and the predicate device. The proposed device was evaluated to show compliance to the standards requirements (listed below) as well as performance characteristics related to the modification of the device.
- . EN 1615:2000, Enteral feeding catheters and enteral giving sets for single use and their connectors - Design and testing
- . ASTM F 2528-06 Standard Test Methods for Enteral Feeding Devices with a Retention Balloon
- . ISO 80369- 3 Small-bore connectors for liquids and gases in healthcare applications – Part 3: Connectors for enteral applications
The following testing was conducted to demonstrate that the device continues to meet the requirements of the product specifications and supports the determination of substantial equivalence.
- . Positive pressure liquid leak
- Leak Test for G-tube 12Fr & 28 Fr
- Resistance to separation from axial load
- Resistance to separation from unscrewing
- . Resistance to overriding
- . Disconnection by unscrewing
- . Stress Cracking
- . Tensile strength
- . Tensile strength of the connections of G-tube 12Fr & 28 Fr
- Dimension verification
- . Balloon burst volume for G-tube 12Fr & 28 Fr
- . Flow rate
- . Simulated Gastric fluids for G-tube 12Fr, 16Fr, 18Fr, & 24Fr
- Biocompatibility evaluation ●
- . Shelf-life (5 years)
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.5980 Gastrointestinal tube and accessories.
(a)
Identification. A gastrointestinal tube and accessories is a device that consists of flexible or semi-rigid tubing used for instilling fluids into, withdrawing fluids from, splinting, or suppressing bleeding of the alimentary tract. This device may incorporate an integral inflatable balloon for retention or hemostasis. This generic type of device includes the hemostatic bag, irrigation and aspiration catheter (gastric, colonic, etc.), rectal catheter, sterile infant gavage set, gastrointestinal string and tubes to locate internal bleeding, double lumen tube for intestinal decompression or intubation, feeding tube, gastroenterostomy tube, Levine tube, nasogastric tube, single lumen tube with mercury weight balloon for intestinal intubation or decompression, and gastro-urological irrigation tray (for gastrological use).(b)
Classification. (1) Class II (special controls). The barium enema retention catheter and tip with or without a bag that is a gastrointestinal tube and accessory or a gastronomy tube holder accessory is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I (general controls) for the dissolvable nasogastric feed tube guide for the nasogastric tube. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 876.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
October 23, 2018
Covidien Alexis Erazo Principal Regulatory Affairs Specialist 15 Hampshire Street Mansfield. Massachusetts 02048
Re: K180622
Trade/Device Name: Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port Regulation Number: 21 CFR 876.5980 Regulation Name: Gastrointestinal tube and accessories Regulatory Class: Class II Product Code: KNT, PIF Dated: September 11, 2018 Received: September 12, 2018
Dear Alexis Erazo:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Daniel G. Walter Jr -S
for
Benjamin R. Fisher. Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K180622
Device Name
Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port
Indications for Use (Describe)
The Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port is indicated for use in an established gastrostomy tract as a replacement tube for the administration of nutrition, fluids, and medications to the stomach of a patient, 2 years and older, that are physically unable to manage nutritional intake through normal mastication and deglutition.
| Type of Use (Select one or both, as applicable): | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port, K180622
Preparation date:
October 17, 2018
Manufacturer's Name:
Covidien 15 Hampshire Street Mansfield, MA 02048
Corresponding Official:
Alexis Erazo, Principal Requlatory Affairs Specialist Phone: 508-452-4673 Alexis.erazo@cardinalhealth.com
Name of Medical Device:
| Trade Name: | Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port |
|---|---|
| Common Name: | Tubes, gastrointestinal |
| Classification Name: | Gastrointestinal tube and accessories |
| Regulation Number: | 21 CFR 876.5980 |
| Product Code: | KNT, PIF |
| Class: | II |
ldentification of Predicate Device:
| 510(k) Number: | K143378 |
|---|---|
| Device Description: | AQUARIUS™ Gastrostomy Replacement Tube |
| Submitter: | Degania Silicone Ltd |
ldentification of Reference Devices:
| 510(k) Number: | K161413 |
|---|---|
| Device Description: | Low Profile Balloon Feeding Device |
| Submitter: | Applied Medical Technology, INC. |
| 510(k) Number: | K951489 |
|---|---|
| Device Description: | MRI'S All Silicone Gastrostomy Tube |
| Submitter: | Manufacturing & Research, Inc. |
| 510(k) Number: | K913784 |
|---|---|
| Device Description: | Dobbhoff Single Pass PEG Kit |
| Submitter: | Biosearch Medical Products, Inc. |
4
Device Description:
The Kangaroo™ Gastrostomy Feeding Tube is a silicone qastrostomy tube with a balloon retention device located at the tip of the tube. An external skin disc is provided on the outer lumen of the device and is used in conjunction with the balloon to provide a secure retention system for the Kanqaroo™ Gastrostomy Feeding Tube. The ENFit Y-Port Enteral Adapter is secured within the funnel end of the Gastrostomy Tube Lumen. The Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port is packaged with a packet of water-soluble jelly used to ease the insertion of the device.
Intended Use/Indications for Use:
The Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port is indicated for use in an established gastrostomy tract as a replacement tube for the administration of nutrition, fluids, and medications to the stomach of a patient, 2 years and older, that are physically unable to manage nutritional intake through normal mastication and deqlutition.
Product Comparison Summary:
The proposed Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port has the same intended use and same general fundamental technological characteristics and as compared to the predicate AQUARIUS™ Gastrostomy Replacement Tube (K143378). Comparison verification testing demonstrates that the Kanqaroo™ Gastrostomy Feeding Tube with ENFit Y-Port does not raise new questions of safety and efficacy that it is as safe and effective as the predicate. Furthermore, the comparison verification testing demonstrates that the performance of the proposed device is substantially equivalent as that of the legally marketed K143378 AQUARIUS™ Gastrostomy Replacement Tube.
Non-Clinical Performance Data:
Laboratory testing was completed to support substantial equivalence between the proposed device and the predicate device. The proposed device was evaluated to show compliance to the standards requirements (listed below) as well as performance characteristics related to the modification of the device.
- . EN 1615:2000, Enteral feeding catheters and enteral giving sets for single use and their connectors - Design and testing
- . ASTM F 2528-06 Standard Test Methods for Enteral Feeding Devices with a Retention Balloon
- . ISO 80369- 3 Small-bore connectors for liquids and gases in healthcare applications – Part 3: Connectors for enteral applications
The following testing was conducted to demonstrate that the device continues to meet the requirements of the product specifications and supports the determination of substantial equivalence.
- . Positive pressure liquid leak
- Leak Test for G-tube 12Fr & 28 Fr
5
- Resistance to separation from axial load
- Resistance to separation from unscrewing
- . Resistance to overriding
- . Disconnection by unscrewing
- . Stress Cracking
- . Tensile strength
- . Tensile strength of the connections of G-tube 12Fr & 28 Fr
- Dimension verification
- . Balloon burst volume for G-tube 12Fr & 28 Fr
- . Flow rate
- . Simulated Gastric fluids for G-tube 12Fr, 16Fr, 18Fr, & 24Fr
- Biocompatibility evaluation ●
- . Shelf-life (5 years)
Clinical Data:
Clinical evaluations were not relied upon for evidence of safety of effectiveness, or for a determination of substantial equivalence.
Conclusion:
The proposed Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port has the same intended use and same qeneral fundamental technological characteristics as compared to the predicate AQUARIUS™ Gastrostomy Replacement Tube (K143378). Comparison verification testing provided demonstrates that the Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port does not raise new questions of safety and efficacy, and that it is as safe and effective as the predicate. Furthermore, the comparison verification testing demonstrates that the performance of the proposed device is substantially equivalent as that of the legally marketed K143378 AQUARIUS™ Gastrostomy Replacement Tube. In addition, the Kangaroo™ Gastrostomy Feeding Tube with ENFit Y-Port has the similar indications for use as the legally marketed Low Profile Balloon Feeding Device by Applied Medical Technologies (K161413). Furthermore, the device design and materials are identical to those of reference devices MRI'S All Silicone Gastrostomy Tube (K951489) and Dobbhoff Single Pass PEG Kit (K913784).